Comité des ONG pour les maladies rares

mercredi 16 novembre 2016

Le 11 novembre 2016, la conférence "L’assemblée générale pour les maladies rares, inaugurant le comité des ONG pour les maladies rares" a eu lieu à New York avec le soutien de la Reine Silvia de Suède et la conférence des ONG en relation consultative avec l’ONU (CoNGO). Cette conférence a été rendue possible grâce au ministère de la santé et des affaires sociales suédois, à la mission permanente de l’ONU en Estonie et au gouvernement de la république de Malte.



Le comité des ONG pour les maladies rares (NGO Committee for Rare Diseases) est un comité établi sous l’égide de la conférence des ONG en relation consultative avec l’ONU (CoNGO). Le comité des ONG pour les maladies rares a été initié par la fondation Agrenska et EURORDIS , puis Maladies Rares International (Rares Diseases International) - RDI. Le but de ce comité est de générer plus de reconnaissance politique par rapport au défi global des maladies rares. Sa création a été approuvée par un vote de 27 des membres de CoNGO en avril 2014. Sa réunion de lancement en tant que comité substantiel au sein de CoNGO s’est tenu en octobre 2015 à New York.


Vous pourrez trouver le programme de la journée en anglais ci-dessous :

Friday 11 November 2016 Conference Room 8 (GA-1B-CR08), United Nations, New York (NY 10017)

Morning Plenary : 10:00 to 13:30

- KeyNote Addresses : 10:00-11:00

1) The United Nations and civil society : CoNGO and CoNGO Committees  ; Mr Cyril Ritchie, President of CoNGO 2011-2018
2) Public Health in the mandate of the United Nations Economic and Social Council  ; Mr Navid Hanif, Director, Office for ECOSOC Support and Coordination, UN Department of Economic and Social Affairs (DESA)
3) Rare Diseases : a common cause at the global Level ; Mr Anders Olauson, Chairman, Ågrenska
4) How it all started : the contribution of the NGO community to advancing the cause of rare diseases
+ Ms Abbey s. Meyers, President Emeritus, National Organization for Rare
Disorders (NORD)
+ Mr terkel Andersen, President of the Board of Officers, EURORDIS-Rare
Diseases Europe ; Chairman of the board, Danish Hemophilia Society
+ Prof Min-Chieh Tseng, Founder, Taiwan Foundation for Rare Disorders ; Dean, College of Social Sciences, National Taipei Universit

- Panel debate 1 : 11:00-13:30 ; The global state of play of rare diseases.

Moderator : Mr Yann Le Cam, Chief Executive, EURORDIS-Rare Diseases Europe ; Council Member, Rare Diseases International (RDI)

5) A call for global action coming from civil society  ; Mr Yann Le Cam, Chief Executive, EURORDIS-Rare Diseases Europe ; Council Member, Rare Diseases International (RDI)
6) Tackling rare diseases internationally through national and regional strategies
+ Europe ; Ms Avril Daly, Vice-President of the board of officers, EURORDIS-Rare Diseases Europe ; Chief Executive, Retina International
+ North America ; Mr Paul Melmeyer, Associate Director of Public Policy, National Organization for Rare Disorders (NORD)
+ Latin America ; Ms Migdalia Denis, Founder, Venezuelan Society for Pulmonary Hypertension ; Governing Board Member, International Alliance of Patients’ Organisations (IAPO)
+ Russia ; Ms Irina V. Myasnikova, President, Interregional Public Organisation
« Help for Patients with Cystic Fibrosis » ; Co-Chair, All-Russia Patients Union
+ Middle East and Central Asia ; Mr Sirous Eftekhari, International Affairs,
Rare Diseases Foundation of Iran (RADOIR)
+ Africa ; Ms Hawa Dramé, Founder, Fondation International Tierno et Mariam
(FITIMA), Burkina Faso and Guinea
+ Japan ; Ms Yukiko Nishimura, President, ASrid (Japanese Advocacy Service for Rare and Intractable Diseases)
+ China ; Ms Rachel Yang, Director of International Affairs, Chinese Organization for Rare Disorders (CORD)
+ Malaysia ; Ir lee Yee Seng, President, Malaysia Lysosomal Diseases Association
+ Australia, Ms Megan Fookes, Founder, Rare Voices Australia ; Council
Member, Rare Diseases International
7) Tackling Rare Diseases Internationally Through Bottom-Up Diagnosis
and Care Strategies

+ Mr lieven Bauwens, Secretary-General, International Federation for Spina Bifida
and Hydrocephalus (IF)
+ Mr Alain Weill  ; President of the Board, World Federation of Hemophilia (WFH)
+ in conversation with Ms Vidhya Ganesh, Deputy Director, Programme Division, United Nations Children’s Fund (UNICEF)

—> Lunch break : 13:30 to 14:30
Buffet to be served by the stairs behind the left side of the Vienna Café

Afternoon Plenary : 14:30 to 18:00

- Panel debate 2 14:30-17:30 ; The way forward : acting globally from within the UN SDGs.

Moderator : Ms Durhane Wong-Rieger, President and CEO, Canadian Organization for Rare Disorders (CORD) ; Council Member, Rare Diseases International (RDI) ; Former Chair of the Governing Board, International Alliance of Patients’ Organisations (IAPO)

8) How to further carry the patients’ voice at the global level to deliver change ? Ms Durhane Wong-Rieger, President and CEO, Canadian Organization for Rare Disorders (CORD) ; Council Member, Rare Diseases International (RDI) ) ; Former Governing Board Chair, International Alliance of Patients’ Organisations (IAPO)
9) The UN Sustainable Development Goals (SDGs) : Implications for Health
in General and Rare Diseases in Particular

+ Ms Lauren Barredo, Manager, Thematic Group on Health, UN Sustainable
Development Solutions Network (SDSN)
+ Dr Nata Menabde, Executive Director, WHO Office at the United Nations,
New York
+ In conversation with Mr Jean-louis Roux, Public Affairs Director, European and International Advocacy, EURORDIS-Rare Diseases Europe
10) Bringing the SDGs to life : spotlight examples of where the eare
disease community can make a contribution

+ Disability and Gender, Ms Maria Montefusco, Secretary of the Council of Nordic Cooperation on Disability, Nordic Center of Welfare and Social Issues in conversation with Dr Gustavo Gonzalez-Canali, Senior Advisor, UN Coordination Division, UN WOMEN
+ Education, Ms Gunilla Jaeger, Psychologist, Ågrenska
+ Employment, Inclusion and Poverty, Video testimonial by Mr Marek Plura, Member of the European Parliament, European Parliament’s Committee on
Employment and Social Affairs ; Vice-President, Disability Intergroup at the
European Parliament in conversation with Ms Daniela Bas, Director, Division for Social Policy and Development (DSPD), UN Department of Economic and Social Affairs (DESA)
+ A Holistic Perspective Mr Tenu Avafia, Human Rights, Law and Treatment Access, HIV, Health and Development Group, United Nations Development Programme (UNDP)
11) Avenues for Global Action : Mobilising all stakeholders in the rare disease
community worldwide on the road to 2030

+ IrdirC : How can international collaboration accelerate research advancements ? Dr Christopher P. Austin, Director, National Center for Advancing Translational Sciences (NCATS) ; Chair, International Rare Disease Research Consortium (IRDiRC)
+ IFPMA : How can the Pharma and biotech Industry help translate scientific opportunities into accessible and affordable treatments ? Dr Philip Vickers, Global Head of Research and Development, Shire on behalf of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
+ orphaNet : How can international classification of rare diseases,
international encyclopedias and resource listings enhance research and
clinical excellence ?
Dr Ana Rath, Director, INSERM US14-OrphaNet
+ ICord : How can a cycle of multi-stakeholder conferences stimulate dialogue and actions in different parts of the W-world ? Mr John Forman, Past-President, International Conference on Rare Diseases and Orphan Drugs (ICORD)

- Closing session : 17:30-18:00

12) Introducing the NGO Committee for Rare Diseases and its Founding Act
« Rare Diseases and the UN Sustainable Development Goals »
 ; Mr Anders Olauson, Chairman, Ågrenska
13) Closing Keynote Addresses with an official statement from H.e. Prime Minister Joseph Muscat and the Government of the republic of Malta on the eve of the Maltese Presidency of the Council of the European Union in 2017